Overview

Effects of PGI2 Analogue Use on the Development of Chronic Allograft Nephropathy

Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of Prostaglandin I2 analogue use on the development of chronic allograft nephropathy and changes in allograft function in prevalent renal transplant recipients
Phase:
Phase 3
Details
Lead Sponsor:
Seoul National University Hospital
Treatments:
Epoprostenol
Tezosentan